Protagonist Therapeutics, Inc (PTGX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.05 | -148.5% |
| 2024 | $4.23 | +404.3% |
| 2023 | $-1.39 | +46.5% |
| 2022 | $-2.60 | +4.1% |
| 2021 | $-2.71 | -41.1% |
| 2020 | $-1.92 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.05 | -148.5% |
| 2024 | $4.23 | +404.3% |
| 2023 | $-1.39 | +46.5% |
| 2022 | $-2.60 | +4.1% |
| 2021 | $-2.71 | -41.1% |
| 2020 | $-1.92 | — |